FDA approves new Alzheimer’s blood test
FDA approves new Alzheimer’s blood test American Hospital Association
Regulatory Approvals
Behind the FDA Approval: ‘Historic’ Iberdomide Trial Spotlights MRD End Point and Potential of CELMoDs Across Myeloma
Behind the FDA Approval: ‘Historic’ Iberdomide Trial Spotlights MRD End Point and Potential of CELMoDs Across Myeloma Targeted Oncology
FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for…
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Locally Advanced or Metastatic Gastric Cancer
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Locally Advanced or Metastatic Gastric Cancer OncLive
Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval
Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval Medical Device Network